RUNX3 and lung adenocarcinoma: Targeted inactivation of Runx3 in mouse lung results in lung adenoma and accelerates Kras-induced development of lung adenocarcinoma as well as loss of Trp53 function, indicating that loss of RUNX3 is a crucial early event in lung tumorigenesis [24].